Establishment Labs Holdings Inc. announced it has entered into an agreement with Seishin Plastic and Aesthetic Surgery Clinic in Japan for Mia Femtech (Mia®). Mia Femtech is Establishment Labs' breakthrough minimally invasive breast aesthetics experience. The patented technologies used with Mia can increase breast shape by 1 to 2 cups in a 15-minute procedure without the need for general anesthesia.
Establishment Labs Holdings Inc.
Equities
ESTA
VGG312491084
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
49.98 USD | +9.80% |
|
+11.85% | +91.35% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+91.35% | 1.25B | |
-6.50% | 179B | |
-5.92% | 98.84B | |
-6.01% | 65.34B | |
+15.46% | 45.41B | |
-7.20% | 44.94B | |
+9.63% | 43.76B | |
+13.20% | 29.01B | |
+19.39% | 25.65B | |
-6.49% | 23.32B |
- Stock Market
- Equities
- ESTA Stock
- News Establishment Labs Holdings Inc.
- Establishment Labs Announces Seishin Plastic and Aesthetic Surgery Clinic in Japan as First Clinic Partner in Global Launch of Mia Femtech